Fayez Sarofim & CO Becton Dickinson & CO Transaction History

Fayez Sarofim & CO

$38.7 Billion
Q3 2024

A detailed history of Fayez Sarofim & CO transactions in Becton Dickinson & CO stock. As of the latest transaction made, Fayez Sarofim & CO holds 1,551 shares of BDX stock, worth $354,387. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,551

Previous 1,551 -0.0%

Holding current value

$354,387

Previous $362,000 3.04%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$225.07 - $246.17 $157,549 - $172,319	-700 Reduced 31.1%	1,551 $362,000
Q4 2023 Feb 14, 2024	SELL	$232.24 - $267.23 $29,030 - $33,403	-125 Reduced 5.26%	2,251 $548,000
Q3 2023 Nov 14, 2023	SELL	$254.9 - $283.59 $122,352 - $136,123	-480 Reduced 16.81%	2,376 $614,000
Q2 2023 Aug 14, 2023	SELL	$238.39 - $265.32 $238 - $265	-1 Reduced 0.04%	2,856 $754,000
Q1 2023 May 11, 2023	BUY	$229.71 - $259.35 $229 - $259	1 Added 0.04%	2,857 $707,000
Q4 2022 Feb 13, 2023	SELL	$218.29 - $256.91 $6,548 - $7,707	-30 Reduced 1.04%	2,856 $726,000
Q3 2022 Nov 14, 2022	SELL	$51.03 - $264.23 $30,260 - $156,688	-593 Reduced 17.05%	2,886 $643,000
Q1 2022 May 16, 2022	SELL	$243.64 - $270.48 $27,774 - $30,834	-114 Reduced 3.17%	3,479 $925,000
Q4 2021 Feb 11, 2022	BUY	$230.08 - $250.94 $23,008 - $25,094	100 Added 2.86%	3,593 $904,000
Q3 2021 Nov 15, 2021	SELL	$232.72 - $256.47 $11,636 - $12,823	-50 Reduced 1.41%	3,493 $859,000
Q2 2021 Aug 13, 2021	SELL	$232.65 - $254.58 $8,142 - $8,910	-35 Reduced 0.98%	3,543 $862,000
Q1 2021 May 13, 2021	BUY	$232.09 - $256.88 $115,116 - $127,412	496 Added 16.09%	3,578 $870,000
Q4 2020 Feb 11, 2021	SELL	$221.92 - $245.94 $175,538 - $194,538	-791 Reduced 20.42%	3,082 $771,000
Q3 2020 Nov 13, 2020	BUY	$215.77 - $276.76 $132,914 - $170,484	616 Added 18.91%	3,873 $901,000
Q2 2020 Aug 11, 2020	SELL	$219.9 - $263.41 $8,136 - $9,746	-37 Reduced 1.12%	3,257 $780,000
Q1 2020 May 12, 2020	SELL	$195.69 - $279.01 $58,707 - $83,703	-300 Reduced 8.35%	3,294 $756,000
Q3 2019 Nov 13, 2019	BUY	$230.58 - $256.08 $51,880 - $57,618	225 Added 6.68%	3,594 $909,000
Q4 2018 Feb 13, 2019	BUY	$204.73 - $257.93 $73,498 - $92,596	359 Added 11.93%	3,369 $759,000
Q2 2018 Aug 14, 2018	BUY	$208.1 - $233.85 $104,050 - $116,925	500 Added 19.92%	3,010 $721,000
Q4 2017 Feb 13, 2018	BUY	$189.0 - $222.64 $16,632 - $19,592	88 Added 3.63%	2,510 $537,000
Q3 2017 Nov 08, 2017	BUY	$186.89 - $198.9 $452,647 - $481,735	2,422	2,422 $474,000

Others Institutions Holding BDX

# of Institutions

1,738

Shares Held

249M

Call Options Held

690K

Put Options Held

787K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $65.2B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fayez Sarofim & CO, based on Form 13F filings with the SEC.

News

Stay updated on Fayez Sarofim & CO with notifications on news.

Account